NEW YORK (GenomeWeb News) – Nanosphere today said that its first-quarter revenues jumped 85 percent year over year as consumables sales rose 123 percent.

The company also said that it secured $27 million in new financing.

The Northbrook, Ill.-based molecular diagnostics firm recorded $2.4 million in revenues for the three months ended March 31, compared to $1.3 million a year ago, and beat the consensus Wall Street estimate of $2.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.